Simplify your online presence. Elevate your brand.

Optain Ai

Optain Ai
Optain Ai

Optain Ai One tap lets any staff member capture a sharp, undilated image. wireless encrypted upload to optain. resolve teleophthalmology grading detects diabetic retinopathy and other conditions with rapid, non invasive imaging—running anywhere care happens, no extra staff needed. Optain delivers an ai backed retinal screening platform that enables non invasive, rapid assessment of eye and cardiovascular conditions via a robotic camera, teleophthalmology, and ai.

Optain Ai
Optain Ai

Optain Ai Integrated ai workflows detect sight threatening eye diseases, including diabetic retinopathy, glaucoma, and age related macular degeneration, and assess cardiovascular disease risk. in the u.s.,. Optain’s assure software uses artificial intelligence (ai) technology to analyse retinal images for features of glaucoma, referrable diabetic retinopathy, and neovascular amd. How does optain’s ai work? optain’s ai algorithms analyze retinal images captured by a portable robotic camera to identify indicators of various health conditions. Optain uses next generation retinal imaging and ai to advance oculomics—the science of identifying disease through the eye. founded by oculomics leader professor ming he, optain’s technology is supported by over a decade of research and 30 peer reviewed publications.

New Ai Company Optain Targets Retinal Imaging
New Ai Company Optain Targets Retinal Imaging

New Ai Company Optain Targets Retinal Imaging How does optain’s ai work? optain’s ai algorithms analyze retinal images captured by a portable robotic camera to identify indicators of various health conditions. Optain uses next generation retinal imaging and ai to advance oculomics—the science of identifying disease through the eye. founded by oculomics leader professor ming he, optain’s technology is supported by over a decade of research and 30 peer reviewed publications. Integrated ai workflows detect sight threatening eye diseases, including diabetic retinopathy, glaucoma, and age related macular degeneration, and assess cardiovascular disease risk. in the u.s., optain delivers rapid teleophthalmology grading to screen for diabetic retinopathy and more. That vision fuels our pioneering work in ai powered oculomics and has produced a fast, non invasive retinal screening platform that can spot glaucoma, diabetic retinopathy, age related macular degeneration, and cardiovascular disease. Track your strength training workouts with optain the ultimate mobile first fitness companion. Optain is transforming preventive health with industry leading ai enabled software and hardware products that noninvasively diagnose eye and systemic health conditions in real time.

Comments are closed.